Fat-forming solitary fibrous tumor is a rare and specific subtype of solitary fibrous tumor. In this case, a mass of 8.3 cm in diameter was found in a 59-year-old male patient's right retroperitoneum, as revealed by abdominal contrast-enhanced computed tomography (CT) images. The tumor exhibited a well-circumscribed nature and histological features characterized by a combination of hemangiopericytomatous vasculature and mature adipose tissue, comprising around 70% of the total tumor composition. Immunohistochemistry staining revealed diffuse positive expression of STAT6 and CD34 in the tumor cells. Based on these findings, the final diagnosis was determined to be a fat-forming solitary fibrous tumor located in the retroperitoneum. It is important to consider other potential differential diagnoses, including angiomyolipoma, dedifferentiated liposarcoma, spindle cell lipoma, and atypical lipomatous tumor/well-differentiated liposarcoma.
Lipoma , Liposarcoma , Solitary Fibrous Tumors , Humans , Male , Middle Aged , Adipose Tissue/metabolism , Lipoma/diagnosis , Lipoma/genetics , Liposarcoma/genetics , Liposarcoma/pathology , Solitary Fibrous Tumors/diagnosis , Solitary Fibrous Tumors/genetics , Solitary Fibrous Tumors/pathology , Tomography, X-Ray Computed
Beige adipocytes in white adipose tissue (WAT) are similar to classical brown adipocytes in that they can burn lipids to produce heat. Thus, an increase in beige adipocyte content in WAT browning would raise energy expenditure and reduce adiposity. Here we report that adipose-specific inactivation of Notch1 or its signaling mediator Rbpj in mice results in browning of WAT and elevated expression of uncoupling protein 1 (Ucp1), a key regulator of thermogenesis. Consequently, as compared to wild-type mice, Notch mutants exhibit elevated energy expenditure, better glucose tolerance and improved insulin sensitivity and are more resistant to high fat diet-induced obesity. By contrast, adipose-specific activation of Notch1 leads to the opposite phenotypes. At the molecular level, constitutive activation of Notch signaling inhibits, whereas Notch inhibition induces, Ppargc1a and Prdm16 transcription in white adipocytes. Notably, pharmacological inhibition of Notch signaling in obese mice ameliorates obesity, reduces blood glucose and increases Ucp1 expression in white fat. Therefore, Notch signaling may be therapeutically targeted to treat obesity and type 2 diabetes.
Adipose Tissue, Brown/drug effects , Adipose Tissue, White/drug effects , Immunoglobulin J Recombination Signal Sequence-Binding Protein/antagonists & inhibitors , Obesity/therapy , Receptor, Notch1/antagonists & inhibitors , Adipocytes, Brown/metabolism , Adipose Tissue, Brown/metabolism , Adipose Tissue, White/metabolism , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Animals , Blood Glucose , Cells, Cultured , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Dibenzazepines/pharmacology , Diet, High-Fat , Energy Metabolism , Female , Glucose/metabolism , Immunoglobulin J Recombination Signal Sequence-Binding Protein/genetics , Ion Channels/biosynthesis , Ion Channels/genetics , Male , Mice , Mice, Inbred C57BL , Mitochondrial Proteins/biosynthesis , Mitochondrial Proteins/genetics , Obesity/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , RNA, Messenger/biosynthesis , Receptor, Notch1/genetics , Signal Transduction , Transcription Factors/antagonists & inhibitors , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcription, Genetic , Uncoupling Protein 1
